These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17658067)

  • 1. [Monoclonal antibody therapy: a literature review].
    Del Debbio CB; Tonon LM; Secoli SR
    Rev Gaucha Enferm; 2007 Mar; 28(1):133-42. PubMed ID: 17658067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4 blockade: autoimmunity as treatment.
    Kapadia D; Fong L
    J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach.
    Epner EM; Saroya BS; Hasanali ZS; Loughran TP
    Exp Hematol; 2016 Mar; 44(3):157-60. PubMed ID: 26802532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on monoclonal antibody therapy in chronic lymphocytic leukemia.
    Zent CS; Kay NE
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):107-13. PubMed ID: 16163170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New solid tumor targets for therapeutic monoclonal antibodies.
    Papkoff J
    Expert Opin Ther Targets; 2007 May; 11(5):585-8. PubMed ID: 17465718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal antibodies and cancer].
    López González JS; Selman Lama M
    Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
    [No Abstract]   [Full Text] [Related]  

  • 8. [Principal therapeutic uses of monoclonal antibodies in oncology].
    Penault-Llorca F; Etessami A; Bourhis J
    Cancer Radiother; 2002 Nov; 6 Suppl 1():24s-28s. PubMed ID: 12587379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches.
    Jurcic JG; Cathcart K; Pinilla-Ibarz J; Scheinberg DA
    Curr Opin Hematol; 2000 Jul; 7(4):247-54. PubMed ID: 10882181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-based therapeutics in oncology.
    Ross J; Gray K; Schenkein D; Greene B; Gray GS; Shulok J; Worland PJ; Celniker A; Rolfe M
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):107-21. PubMed ID: 12597355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An overview of antibody-based cancer therapy].
    Miao QF; Shao RG; Zhen YS
    Yao Xue Xue Bao; 2012 Oct; 47(10):1261-8. PubMed ID: 23289136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors.
    Charmsaz S; Scott AM; Boyd AW
    Exp Hematol; 2017 Oct; 54():31-39. PubMed ID: 28751189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-based immunotherapy in high-risk neuroblastoma.
    Johnson E; Dean SM; Sondel PM
    Expert Rev Mol Med; 2007 Dec; 9(34):1-21. PubMed ID: 18081947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody therapy for cancer.
    Lovett DR; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1991; 12():147-63. PubMed ID: 1931442
    [No Abstract]   [Full Text] [Related]  

  • 15. Bispecific monoclonal antibodies for the targeting of type I ribosome-inactivating proteins against hematological malignancies.
    Ferrini S; Sforzini S; Canevari S
    Methods Mol Biol; 2001; 166():177-92. PubMed ID: 11217367
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monoclonal antibodies in the treatment of hematological malignancies].
    Itälä M
    Duodecim; 2002; 118(16):1647-56. PubMed ID: 12271942
    [No Abstract]   [Full Text] [Related]  

  • 17. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
    Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technology evaluation: edrecolomab, Centocor Inc.
    Abicht A; Lochmüller H
    Curr Opin Mol Ther; 2000 Oct; 2(5):593-600. PubMed ID: 11249762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intervention in receptor tyrosine kinase-mediated pathways: recombinant antibody fusion proteins targeted to ErbB2.
    Wels W; Groner B; Hynes NE
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():113-28. PubMed ID: 8815001
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapeutic approaches for hematologic malignancies.
    Caligiuri MA; Velardi A; Scheinberg DA; Borrello IM
    Hematology Am Soc Hematol Educ Program; 2004; ():337-53. PubMed ID: 15561691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.